Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and β-catenin

Molecular and Cellular Biology

Volumn 24, Issue 24, 2004, Pages 10689-10702

  Labalette, Charlotte ^a   Renard, Claire Angelíque ^a   Neuveut, Christine ^a   Buendia, Marie Annick ^a   Wei, Yu ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; ANDROGEN RECEPTOR; BETA CATENIN; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE PCAF; LIM PROTEIN; LYMPHOID ENHANCER FACTOR 1; PROTEIN FHL2; UNCLASSIFIED DRUG; WNT PROTEIN;

ACETYLATION; ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION INITIATION;

ACETYLATION; ANIMALS; BACULOVIRIDAE; BETA CATENIN; CADHERINS; CELL LINE; CELL LINE, TUMOR; CELL NUCLEUS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOSKELETAL PROTEINS; EMBRYO; FIBROBLASTS; GLUTATHIONE TRANSFERASE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOBLOTTING; LUCIFERASES; MUSCLE PROTEINS; NEOPLASM PROTEINS; PRECIPITIN TESTS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANDROGEN; RECOMBINANT PROTEINS; RNA; SPODOPTERA; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; ZINC FINGERS;

ANIMALIA; MURINAE;

EID: 10044280582     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.24.10689-10702.2004     Document Type: Article

References (46)

1. Barker, N., A. Hurlstone, H. Musisi, A. Miles, M. Bienz, and H. Clevers. 2001. The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation. EMBO J. 20:4935-4943.
2. Batlle E., J. T. Henderson, H. Beghtel, M. M. van den Born, E. Sancho, G. Huls, J. Meeldijk, J. Robertson, M. van de Wetering, T. Pawson, and H. Clevers. 2002. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 111:251-263.
3. Boisvert, F. M., M. J. Kruhlak, A. K. Box, M. J. Hendzel, and D. P. Bazett-Jones. 2001. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. J. Cell Biol. 152:1099-1106.
4. Brannon, M., M. Gomperts, L. Sumoy, R. T. Moon, and D. Kimelman. 1997. A beta-catenin/XTcf-3 complex binds to the siamois promoter to regulate dorsal axis specification in Xenopus. Genes Dev. 11:2359-2370.
5. Brantjes, H., N. Barker, J. van Es, and H. Clevers. 2002. TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling. Biol. Chem. 383:255-261.
6. Chan, H. M., and N. B. La Thangue. 2001. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114:2363-2373.
7. Chen, D., W. Xu, E. Bales, C. Colmenares, M. Conacci-Sorrell, S. Ishii, E. Stavnezer, J. Campisi, D. E. Fisher, A. Ben-Ze'ev, and E. E. Medrano. 2003. SKI activates Wnt/beta-catenin signaling in human melanoma. Cancer Res. 63:6626-6634.
8. Chrivia, J. C., R. P. Kwok, N. Lamb, M. Hagiwara, M. R. Montminy, and R. H. Goodman. 1993. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365:855-859.
9. Chu, P. H., W. M. Bardwell, Y. Gu, J. Ross, Jr., and J. Chen. 2000. FHL2 (SLIM3) is not essential for cardiac development and function. Mol. Cell. Biol. 20:7460-7462.
10. Dawid, I. B., J. J. Breen, and R. Toyama. 1998. LIM domains: multiple roles as adapters and functional modifiers in protein interactions. Trends Genet. 14:156-162.
11. Du, X., P. Hublitz, T. Gunther, D. Wilhelm, C. Englert, and R. Schule. 2002. The LIM-only coactivator FHL2 modulates WT1 transcriptional activity during gonadal differentiation. Biochim. Biophys. Acta 1577:93-101.
12. El Mourabit, H., S. Muller, L. Tunggal, M. Paulsson, and M. Aumailley. 2003. Characterization of recombinant and natural forms of the human LIM domain-containing protein FHL2. Protein Expr. Purif. 32:95-103.
13. Fimia, G. M., D. De Cesare, and P. Sassone-Corsi. 1999. CBP-independent activation of CREM and CREB by the LIM-only protein ACT. Nature 398:165-169.
14. Fimia, G. M., D. De Cesare, and P. Sassone-Corsi. 2000. A family of LIM-only transcriptional coactivators: tissue-specific expression and selective activation of CREB and CREM. Mol. Cell. Biol. 20:8613-8622.
15. Giles, R. H., J. H. van Es, and H. Clevers. 2003. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys. Acta 1653:1-24.
16. He, T. C., A. B. Sparks, C. Rago, H. Hermeking, L. Zawel, L. T. da Costa, P. J. Morin, B. Vogelstein, and K. W. Kinzler. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512.
17. Hecht, A., C. M. Litterst, O. Huber, and R. Kemler. 1999. Functional characterization of multiple transactivating elements in beta-catenin, some of which interact with the TATA-binding protein in vitro. J. Biol. Chem. 274:18017-18025.
18. Hecht, A., K. Vleminckx, M. P. Stemmler, F. van Roy, and R. Kemler. 2000. The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates. EMBO J. 19:1839-1850.
19. Kiernan, R., V. Bres, R. W. Ng, M. P. Coudart, S. El Messaoudi, C. Sardet, D. Y. Jin, S. Emiliani, and M. Benkirane. 2003. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J. Biol. Chem. 278:2758-2766.
20. Kong, Y., J. M. Shelton, B. Rothermel, X. Li, J. A. Richardson, R. Bassel-Duby, and R. S. Williams. 2001. Cardiac-specific LIM protein FHL2 modifies the hypertrophic response to beta-adrenergic stimulation. Circulation 103:2731-2738.
21. Kramps, T., O. Peter, E. Brunner, D. Nellen, B. Froesch, S. Chatterjee, M. Murone, S. Zullig, and K. Basler. 2002. Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex. Cell 109:47-60
22. Kung, A. L., V. I. Rebel, R. T. Bronson, L. E. Ch'ng, C. A. Sieff, D. M. Livingston, and T. P. Yao. 2000. Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev. 14:272-277.
23. Lee, Y. H., S. S. Koh, X. Zhang, X. Cheng, and M. R. Stallcup. 2002. Synergy among nuclear receptor coactivators: selective requirement for protein methyltransferase and acetyltransferase activities. Mol. Cell. Biol. 22:3621-3632.
24. Lehrmann, H., L. L. Pritchard, and A. Harel-Bellan. 2002. Historic acetyltransferases and deacetylases in the control of cell proliferation and differ-entiation. Adv. Cancer Res. 86:41-65.
25. Levy, L., C. Neuveut, C. A. Renard, P. Charneau, S. Branchereau, F. Gauthier, J. T. Van Nhieu, D. Cherqui, A. F. Petit-Bertron, D. Mathieu, and M. A. Buendia. 2002. Transcriptional activation of interleukin-8 by betacatenin-Tcf4. J. Biol. Chem. 277:42386-42393.
26. Levy, L., Y. Wei, C. Labalette, Y. Wu, C. A. Renard, M. A. Buendia, and C. Neuveut. 2004. Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction. Mol. Cell. Biol. 24:3404-3414.
27. Martin, B., R. Schneider, S. Janetzky, Z. Waibler, P. Pandur, M. Kuhl, J. Behrens, K. von der Mark, A. Starzinski-Powitz, and V. Wixler 2002. The LIM-only protein FHL2 interacts with beta-catenin and promotes differentiation of mouse myoblasts. J. Cell Biol. 159:113-122.
28. Matos, A. R., A. d'Arcy, M. Franca, S. Petres, L. Edelman, J. Kader, Y. Zuily-Fodil, and A. T. Pham-Thi. 2001. A novel patatin-like gene stimulated by drought stress encodes a galactolipid acyl hydrolase. FEBS Lett. 491:188-192.
29. Miyagishi, M., R. Fujii, M. Hatta, E. Yoshida, N. Araya, A. Nagafuchi, S. Ishihara, T. Nakajima, and A. Fukamizu. 2000. Regulation of Lef-mediated transcription and p53-dependent pathway by associating beta-catenin with CBP/p300. J. Biol. Chem. 275:35170-35175.
30. Morlon, A., and P. Sassone-Corsi. 2003. The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1. Proc. Natl. Acad. Sci. USA 100:3977-3982.
31. Muller, J. M., U. Isele, E. Metzger, A. Rempel, M. Moser, A. Pscherer, T. Breyer, C. Holubarsch, R. Buettner, and R. Schule. 2000. FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J. 19:359-369.
32. Muller, J. M., E. Metzger, H. Greschik, A. K. Bosserhoff, L. Mercep, R. Buettner, and R. Schule. 2002. The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus. EMBO J. 21:736-748.
33. Peifer, M., and P. Polakis. 2000. Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 287:1606-1609.
34. Renard, C. A., G. Fourel, M. P. Bralet, C. Degott, A. De La Coste, C. Perret, P. Tiollais, and M. A. Buendia. 2000. Hepatocellular carcinoma in WHV/N-myc 2 transgenic mice: oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles. Oncogene 19:2678-2686.
35. Shtutman, M., J. Zhurinsky, M. Oren, E. Levina, and A. Ben-Ze'ev. 2002. PML is a target gene of beta-catenin and plakoglobin, and coactivates beta-catenin-mediated transcription. Cancer Res. 62:5947-5954.
36. Shtutman, M., J. Zhurinsky, I. Simcha, C. Albanese, M. D'Amico, R. Pestell, and A. Ben-Ze'ev. 1999. The cyclin D1 gene is a target of the beta-catenin/ LEF-1 pathway. Proc. Natl. Acad. Sci. USA 96:5522-5527.
37. Stilo, R., A. Leonardi, L. Formisano, B. Di Jeso, P. Vito, and D. Liguoro. 2002. TUCAN/CARDINAL and DRAL participate in a common pathway for modulation of NF-kappaB activation. FEBS Lett. 521:165-169.
38. Sun, Y., F. T. Kolligs, M. O. Hottiger, R. Mosavin, E. R. Fearon, and G. J. Nabel. 2000. Regulation of beta-catenin transformation by the p300 transcriptional coactivator. Proc. Natl. Acad. Sci. USA 97:12613-12618.
39. Takemaru, K. I., and R. T. Moon. 2000. The transcriptional coactivator CBP interacts with beta-catenin to activate gene expression. J. Cell Biol. 149:249-254.
40. Tetsu, O., and F. McCormick. 1999. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426.
41. Townsley, F. M., A. Cliffe, and M. Bienz. 2004. Pygopus and Legless target Armadillo/beta-catenin to the nucleus to enable its transcriptional co-activator function. Nat. Cell Biol. 6:626-633.
42. Truica, C. I., S. Byers, and E. P. Gelmann. 2000. Beta-catenin affects androgen receptor transcriptional activity and ligand specificity. Cancer Res. 60:4709-4713.
43. Wei, Y., M. Fabre, S. Branchereau, F. Gauthier, G. Perilongo, and M. A. Buendia. 2000. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas. Oncogene 19:498-504.
44. Wei, Y., C. A. Renard, C. Labalette, Y. Wu, L. Levy, C. Neuveut, X. Prieur, M. Flajolet, S. Prigent, and M. A. Buendia. 2003. Identification of the LIM protein FHL2 as a coactivator of beta-catenin. J. Biol. Chem. 278:5188-5194.
45. Wolf, D., M. Rodova, E. A. Miska, J. P. Calvet, and T. Kouzarides. 2002. Acetylation of beta-catenin by CREB-binding protein (CBP). J. Biol. Chem. 277:25562-25567.
46. INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 15:203-211.